Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$31.15 - $33.39 $150,111 - $160,906
4,819 Added 35.7%
18,318 $608,000
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $417,119 - $452,891
13,499 New
13,499 $426,000
Q4 2021

Feb 14, 2022

SELL
$17.46 - $21.61 $842,951 - $1.04 Million
-48,279 Reduced 65.98%
24,891 $508,000
Q3 2021

Nov 15, 2021

SELL
$17.35 - $22.5 $1.15 Million - $1.49 Million
-66,266 Reduced 47.52%
73,170 $1.41 Million
Q2 2021

Aug 11, 2021

BUY
$18.01 - $28.32 $2.15 Million - $3.38 Million
119,351 Added 594.23%
139,436 $3.09 Million
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $702,737 - $967,660
-44,675 Reduced 68.99%
20,085 $375,000
Q3 2020

Nov 16, 2020

SELL
$13.54 - $26.41 $719,244 - $1.4 Million
-53,120 Reduced 45.06%
64,760 $1.1 Million
Q2 2020

Aug 14, 2020

BUY
$7.84 - $23.29 $227,501 - $675,829
29,018 Added 32.66%
117,880 $2.75 Million
Q1 2020

May 15, 2020

BUY
$5.57 - $11.5 $318,258 - $657,087
57,138 Added 180.11%
88,862 $746,000
Q4 2019

Feb 14, 2020

BUY
$7.9 - $10.14 $47,818 - $61,377
6,053 Added 23.58%
31,724 $310,000
Q3 2019

Nov 14, 2019

SELL
$9.17 - $12.01 $46,455 - $60,842
-5,066 Reduced 16.48%
25,671 $244,000
Q2 2019

Aug 16, 2019

BUY
$10.88 - $17.6 $96,962 - $156,851
8,912 Added 40.83%
30,737 $365,000
Q2 2019

Aug 14, 2019

SELL
$10.88 - $17.6 $332,231 - $537,433
-30,536 Reduced 58.32%
21,825 $259,000
Q4 2017

Feb 14, 2018

BUY
$13.55 - $15.8 $316,541 - $369,103
23,361 Added 80.56%
52,361 $733,000
Q3 2017

Nov 14, 2017

BUY
$13.45 - $14.35 $390,050 - $416,150
29,000
29,000 $415,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.